Prediction of colorectal cancer diagnosis based on circulating plasma proteins

Abstract Non‐invasive detection of colorectal cancer with blood‐based markers is a critical clinical need. Here we describe a phased mass spectrometry‐based approach for the discovery, screening, and validation of circulating protein biomarkers with diagnostic value. Initially, we profiled human pri...

Full description

Saved in:
Bibliographic Details
Main Authors: Silvia Surinova, Meena Choi, Sha Tao, Peter J Schüffler, Ching‐Yun Chang, Timothy Clough, Kamil Vysloužil, Marta Khoylou, Josef Srovnal, Yansheng Liu, Mariette Matondo, Ruth Hüttenhain, Hendrik Weisser, Joachim M Buhmann, Marián Hajdúch, Hermann Brenner, Olga Vitek, Ruedi Aebersold
Format: Article
Language:English
Published: Springer Nature 2015-08-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.201404873
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849235066225426432
author Silvia Surinova
Meena Choi
Sha Tao
Peter J Schüffler
Ching‐Yun Chang
Timothy Clough
Kamil Vysloužil
Marta Khoylou
Josef Srovnal
Yansheng Liu
Mariette Matondo
Ruth Hüttenhain
Hendrik Weisser
Joachim M Buhmann
Marián Hajdúch
Hermann Brenner
Olga Vitek
Ruedi Aebersold
author_facet Silvia Surinova
Meena Choi
Sha Tao
Peter J Schüffler
Ching‐Yun Chang
Timothy Clough
Kamil Vysloužil
Marta Khoylou
Josef Srovnal
Yansheng Liu
Mariette Matondo
Ruth Hüttenhain
Hendrik Weisser
Joachim M Buhmann
Marián Hajdúch
Hermann Brenner
Olga Vitek
Ruedi Aebersold
author_sort Silvia Surinova
collection DOAJ
description Abstract Non‐invasive detection of colorectal cancer with blood‐based markers is a critical clinical need. Here we describe a phased mass spectrometry‐based approach for the discovery, screening, and validation of circulating protein biomarkers with diagnostic value. Initially, we profiled human primary tumor tissue epithelia and characterized about 300 secreted and cell surface candidate glycoproteins. These candidates were then screened in patient systemic circulation to identify detectable candidates in blood plasma. An 88‐plex targeting method was established to systematically monitor these proteins in two large and independent cohorts of plasma samples, which generated quantitative clinical datasets at an unprecedented scale. The data were deployed to develop and evaluate a five‐protein biomarker signature for colorectal cancer detection.
format Article
id doaj-art-38dba3731a4d435cbe003ef84e6e0f61
institution Kabale University
issn 1757-4676
1757-4684
language English
publishDate 2015-08-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj-art-38dba3731a4d435cbe003ef84e6e0f612025-08-20T04:02:55ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842015-08-01791166117810.15252/emmm.201404873Prediction of colorectal cancer diagnosis based on circulating plasma proteinsSilvia Surinova0Meena Choi1Sha Tao2Peter J Schüffler3Ching‐Yun Chang4Timothy Clough5Kamil Vysloužil6Marta Khoylou7Josef Srovnal8Yansheng Liu9Mariette Matondo10Ruth Hüttenhain11Hendrik Weisser12Joachim M Buhmann13Marián Hajdúch14Hermann Brenner15Olga Vitek16Ruedi Aebersold17Department of Biology, Institute of Molecular Systems Biology, ETH ZurichDepartment of Statistics, Purdue UniversityDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ)Department of Computer Science, Institute for Machine Learning, ETH ZurichDepartment of Statistics, Purdue UniversityDepartment of Statistics, Purdue UniversityDepartment of Surgery, University Hospital in OlomoucInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký UniversityInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký UniversityDepartment of Biology, Institute of Molecular Systems Biology, ETH ZurichDepartment of Biology, Institute of Molecular Systems Biology, ETH ZurichDepartment of Biology, Institute of Molecular Systems Biology, ETH ZurichDepartment of Biology, Institute of Molecular Systems Biology, ETH ZurichDepartment of Computer Science, Institute for Machine Learning, ETH ZurichInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký UniversityDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ)Department of Statistics, Purdue UniversityDepartment of Biology, Institute of Molecular Systems Biology, ETH ZurichAbstract Non‐invasive detection of colorectal cancer with blood‐based markers is a critical clinical need. Here we describe a phased mass spectrometry‐based approach for the discovery, screening, and validation of circulating protein biomarkers with diagnostic value. Initially, we profiled human primary tumor tissue epithelia and characterized about 300 secreted and cell surface candidate glycoproteins. These candidates were then screened in patient systemic circulation to identify detectable candidates in blood plasma. An 88‐plex targeting method was established to systematically monitor these proteins in two large and independent cohorts of plasma samples, which generated quantitative clinical datasets at an unprecedented scale. The data were deployed to develop and evaluate a five‐protein biomarker signature for colorectal cancer detection.https://doi.org/10.15252/emmm.201404873colorectal cancerdiagnostic protein biomarkerdiscovery‐driven and targeted proteomics
spellingShingle Silvia Surinova
Meena Choi
Sha Tao
Peter J Schüffler
Ching‐Yun Chang
Timothy Clough
Kamil Vysloužil
Marta Khoylou
Josef Srovnal
Yansheng Liu
Mariette Matondo
Ruth Hüttenhain
Hendrik Weisser
Joachim M Buhmann
Marián Hajdúch
Hermann Brenner
Olga Vitek
Ruedi Aebersold
Prediction of colorectal cancer diagnosis based on circulating plasma proteins
EMBO Molecular Medicine
colorectal cancer
diagnostic protein biomarker
discovery‐driven and targeted proteomics
title Prediction of colorectal cancer diagnosis based on circulating plasma proteins
title_full Prediction of colorectal cancer diagnosis based on circulating plasma proteins
title_fullStr Prediction of colorectal cancer diagnosis based on circulating plasma proteins
title_full_unstemmed Prediction of colorectal cancer diagnosis based on circulating plasma proteins
title_short Prediction of colorectal cancer diagnosis based on circulating plasma proteins
title_sort prediction of colorectal cancer diagnosis based on circulating plasma proteins
topic colorectal cancer
diagnostic protein biomarker
discovery‐driven and targeted proteomics
url https://doi.org/10.15252/emmm.201404873
work_keys_str_mv AT silviasurinova predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT meenachoi predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT shatao predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT peterjschuffler predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT chingyunchang predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT timothyclough predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT kamilvyslouzil predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT martakhoylou predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT josefsrovnal predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT yanshengliu predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT mariettematondo predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT ruthhuttenhain predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT hendrikweisser predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT joachimmbuhmann predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT marianhajduch predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT hermannbrenner predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT olgavitek predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins
AT ruediaebersold predictionofcolorectalcancerdiagnosisbasedoncirculatingplasmaproteins